HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ALEBUND-B

31.260

+0.1200.39%

Volume:241.50K

Turnover:7.46M

Market Cap:10.88B

PE:-10.18

High:31.720

Open:31.000

Low:30.020

Close:31.140

52wk High:46.820

52wk Low:22.720

Shares:348.00M

HK Float Shares:236.00M

Volume Ratio:0.54

T/O Rate:0.10%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-3.071

ROE:--

ROA:-33.01%

PB:6.63

PE(LYR):-10.18

PS:76.19

Loading ...

Overview Company News Filings

Alebund Pharmaceuticals Says no Market Purchases Made for Price Stabilization During IPO Stabilisation Period

Tencent Holdings Boosts Stake in ALEBUND-B with 238,500 Share Purchase

ALEBUND-B: Tencent Holdings Limited Acquires Shares, Long Position Rises to 10.09%

Alebund Pharma adopts electronic dissemination of corporate communications under HKEX paperless regime

Bulletin Express

Alebund Pharmaceuticals Adopts Fully Electronic Dissemination of Corporate Communications

Bulletin Express

Alebund Pharma Doses First Patient in Global Phase 2b Hyperphosphatemia Trial

MT Newswires Live

ALEBUND-B Advances Global Phase IIb Trial for Hyperphosphatemia Treatment with First Patient Dosed

Alebund Pharmaceuticals, R1 Therapeutics Partner on Global Development of AP306 Outside Greater China

Alebund Pharmaceuticals Announces First Participant Randomized and Dosed in Global Phase Iib Multi-regional Clinical Trial of AP306 for Hyperphosphatemia

THOMSON REUTERS

ALEBUND-B Shares Surge Over 11% in Morning Session Following Major Institutional Buys; AP301 Nears NDA Submission

Movement Alert｜Alebund Pharmaceuticals-B Falls 7.56% in Regular Trading, Post-IPO Volatile Pattern Persists as Stock Retreats Over 40% From High

Movement Alert｜Alebund Pharmaceuticals-B Declines 5.26% in Regular Trading, Post-IPO Volatile Pattern Extends as Short-Term Profit-Taking Continues

Movement Alert｜Alebund Pharmaceuticals-B Falls 5.4% in Regular Trading, Short-Term Profit-Taking After Prior Session Surge

ALEBUND-B Shares Surge Over 10% Intraday Following Significant Stake Increases by GIC and LAV

Movement Alert｜Alebund Pharmaceuticals-B Rises 5.07% in Regular Trading, Post-IPO Recovery Extends on Institutional Backing and NDA Progress

Movement Alert｜Alebund Pharmaceuticals-B Falls 8.32% in Regular Trading, Post-IPO Correction Extends After First-Day Doubling

Alebund Pharmaceuticals Jiangsu (SEHK:9637) Jumps After IPO But Is The Valuation Already Priced In

Simply Wall St.

Major Institutional Investors Increase Holdings in ALEBUND-B, Investing Over HK$58 Million

ALEBUND-B Shares Surge Over 13% in Early Trading as AP301 Nears Commercial Launch Following Recent Sell-Off

Movement Alert｜Alebund Pharmaceuticals-B Rises 7.92% in Regular Trading, Trading at 28.74 HKD

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/09637/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"09637","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09637\",,,,,undefined,":{"symbol":"09637","market":"HK","secType":"STK","nameCN":"ALEBUND-B","latestPrice":31.26,"timestamp":1787904511958,"preClose":31.14,"halted":0,"volume":241496,"delay":0,"changeRate":0.0038535645472061977,"floatShares":236000000,"shares":348000000,"eps":-3.071284,"marketStatus":"Not Yet Opened","change":0.12,"latestTime":"08-28 16:08:31","open":31,"high":31.72,"low":30.02,"amount":7458154,"amplitude":0.054592,"askPrice":31.26,"askSize":200,"bidPrice":31.08,"bidSize":1000,"shortable":0,"etf":0,"ttmEps":-2.326,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788139800000},"marketStatusCode":0,"adr":0,"listingDate":1782662400000,"exchange":"SEHK","adjPreClose":31.14,"openAndCloseTimeList":[[1787880600000,1787889600000],[1787893200000,1787904000000]],"volumeRatio":0.5421515803867433,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09637\",,,,,undefined,":{"symbol":"09637","floatShares":236000000,"roa":"-33.01%","roe":"--","lyrEps":-3.071284,"volumeRatio":0.5421515803867433,"shares":348000000,"dividePrice":0,"high":31.72,"amplitude":0.054592,"preClose":31.14,"low":30.02,"week52Low":22.72,"pbRate":"6.63","psRate":"76.19","week52High":46.82,"institutionHeld":0,"latestPrice":31.26,"committee":0.666667,"eps":-3.071284,"divideRate":0,"volume":241496,"delay":0,"ttmEps":-2.326,"open":31,"prevYearClose":22.6,"prevWeekClose":31.26,"prevMonthClose":27.24,"prevQuarterClose":45.92,"fiveDayClose":33.12,"twentyDayClose":27.24,"sixtyDayClose":22.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/09637\",params:#limit:5,,,undefined,":[{"date":"2026-08-26","symbol":"09637","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787707800000,"name":null,"time":"","dateTimestamp":1787673600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"09637\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"09637\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":1,"buy":0,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":1,"analysts":3,"updateTime":1787846400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/09637\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"09637","date":"2026-08-28","current":-13.439381,"percent":0.465116,"low":-18.066068,"twenty":-13.077865,"median":-11.990608,"eighty":-10.959851,"high":-8.87585,"avg":-12.238532,"sd":1.702985,"marketCap":10623780741},"quantilePoints":[{"date":"2026-06-26","current":-8.87585,"twenty":-8.87585,"median":-8.87585,"eighty":-8.87585,"marketCap":7680660420},{"date":"2026-07-03","current":-11.883178,"twenty":-18.03155,"median":-11.883178,"eighty":-9.78101,"marketCap":10290725554},{"date":"2026-07-10","current":-12.164969,"twenty":-13.966639,"median":-11.847257,"eighty":-11.12129,"marketCap":10521825071},{"date":"2026-07-17","current":-10.947234,"twenty":-12.322489,"median":-11.455859,"eighty":-10.783874,"marketCap":9502268378},{"date":"2026-07-24","current":-11.320561,"twenty":-11.939536,"median":-11.377389,"eighty":-10.939493,"marketCap":9828526520},{"date":"2026-07-31","current":-10.642718,"twenty":-11.840073,"median":-11.194259,"eighty":-10.78337,"marketCap":9257574772},{"date":"2026-08-07","current":-12.743391,"twenty":-12.396338,"median":-11.399787,"eighty":-10.889159,"marketCap":11106370909},{"date":"2026-08-14","current":-13.03884,"twenty":-12.987078,"median":-11.462395,"eighty":-10.903987,"marketCap":11378252693},{"date":"2026-08-21","current":-12.870195,"twenty":-13.077865,"median":-11.725167,"eighty":-10.931752,"marketCap":11255905890},{"date":"2026-08-28","current":-12.144658,"twenty":-13.077865,"median":-11.990608,"eighty":-10.959851,"marketCap":10623780741}],"updateTime":1788107398471},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"09637\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2653071567","title":"Alebund Pharmaceuticals Says no Market Purchases Made for Price Stabilization During IPO Stabilisation Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2653071567","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653071567?lang=en_us&edition=fundamental","pubTime":"2026-07-24 16:32","pubTimestamp":1784881925,"startTime":"0","endTime":"0","summary":"Alebund Pharmaceuticals says no market purchases made for price stabilization during IPO stabilisation periodAlebund Pharmaceuticals (Jiangsu) fully exercised its over-allotment option on July 24, 202","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260724:nNDL1Bj1ks:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JEF","BK1191","BK4559","BK4127","09637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118027382","title":"Tencent Holdings Boosts Stake in ALEBUND-B with 238,500 Share Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=1118027382","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118027382?lang=en_us&edition=fundamental","pubTime":"2026-07-23 19:36","pubTimestamp":1784806597,"startTime":"0","endTime":"0","summary":"Information from the Hong Kong Stock Exchange reveals that on July 17, Tencent Holdings Limited increased its holding in ALEBUND-B (09637) by 238,500 shares.The transaction was executed at an average...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09637","BK1515","BK4504","159938","BK1191","EWH","BK4588","BK1574","BK4550","BK4585","EDZ","BK1161","BK4581","IEMG","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167044050","title":"ALEBUND-B: Tencent Holdings Limited Acquires Shares, Long Position Rises to 10.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=1167044050","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167044050?lang=en_us&edition=fundamental","pubTime":"2026-07-23 17:12","pubTimestamp":1784797975,"startTime":"0","endTime":"0","summary":"Tencent Holdings Limited bought 238,500 shares of ALEBUND-B stock at an average of HKD 27.9667 per share on July 17, 2026, involving about HKD 6.67 million.Prior to the acquisition, Tencent Holdings...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185122732","title":"Alebund Pharma adopts electronic dissemination of corporate communications under HKEX paperless regime","url":"https://stock-news.laohu8.com/highlight/detail?id=1185122732","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185122732?lang=en_us&edition=fundamental","pubTime":"2026-07-22 17:42","pubTimestamp":1784713347,"startTime":"0","endTime":"0","summary":"Alebund Pharmaceuticals (Jiangsu) Limited announced that, in line with Rule 2.07A of the Hong Kong Stock Exchange’s paperless listing regime effective 31 December 2023, all future corporate...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155137463","title":"Alebund Pharmaceuticals Adopts Fully Electronic Dissemination of Corporate Communications","url":"https://stock-news.laohu8.com/highlight/detail?id=1155137463","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155137463?lang=en_us&edition=fundamental","pubTime":"2026-07-22 17:21","pubTimestamp":1784712104,"startTime":"0","endTime":"0","summary":"Alebund Pharmaceuticals (Jiangsu) Limited (“Alebund”) announced that, in line with Rule 2.07A of the Hong Kong Stock Exchange’s paperless listing regime effective 31 December 2023, the company will...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653378085","title":"Alebund Pharma Doses First Patient in Global Phase 2b Hyperphosphatemia Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2653378085","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653378085?lang=en_us&edition=fundamental","pubTime":"2026-07-22 10:32","pubTimestamp":1784687579,"startTime":"0","endTime":"0","summary":"Alebund Pharmaceuticals (HKG:9637) said that the first participant has been randomized and dosed in a global phase 2b clinical trial evaluating AP306 for hyperphosphatemia in patients receiving mainte","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["09637","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188002342","title":"ALEBUND-B Advances Global Phase IIb Trial for Hyperphosphatemia Treatment with First Patient Dosed","url":"https://stock-news.laohu8.com/highlight/detail?id=1188002342","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188002342?lang=en_us&edition=fundamental","pubTime":"2026-07-21 20:03","pubTimestamp":1784635393,"startTime":"0","endTime":"0","summary":"Global Phase IIb multi-regional clinical trial for AP306, targeting hyperphosphatemia in patients on maintenance hemodialysis, has achieved a significant milestone with the first patient randomized...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","BK1574","PSYK","09637","BK1515","IBBJ","MDTX","09939","BMED","BK1191","BK1161","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653716972","title":"Alebund Pharmaceuticals, R1 Therapeutics Partner on Global Development of AP306 Outside Greater China","url":"https://stock-news.laohu8.com/highlight/detail?id=2653716972","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653716972?lang=en_us&edition=fundamental","pubTime":"2026-07-21 19:01","pubTimestamp":1784631708,"startTime":"0","endTime":"0","summary":"Alebund Pharmaceuticals, R1 Therapeutics partner on global development of AP306 outside Greater ChinaAlebund Pharmaceuticals granted R1 Therapeutics an exclusive license for AP306 outside mainland Chi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nNDL6LWnHG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09637","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653271584","title":"Alebund Pharmaceuticals Announces First Participant Randomized and Dosed in Global Phase Iib Multi-regional Clinical Trial of AP306 for Hyperphosphatemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2653271584","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653271584?lang=en_us&edition=fundamental","pubTime":"2026-07-21 19:00","pubTimestamp":1784631602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nTUA2BSV3K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["09637","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182922213","title":"ALEBUND-B Shares Surge Over 11% in Morning Session Following Major Institutional Buys; AP301 Nears NDA Submission","url":"https://stock-news.laohu8.com/highlight/detail?id=1182922213","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182922213?lang=en_us&edition=fundamental","pubTime":"2026-07-15 10:54","pubTimestamp":1784084068,"startTime":"0","endTime":"0","summary":"Shares of ALEBUND-B (ASX: 09637) surged more than 11% during the morning trading session. At the time of writing, the stock was up 9.62% to HK$30.54, with a turnover of HK$4.20 million. On June 29th,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GIC","KCAI","BK1574","BK1191","BK1515","09637","BK4585","09939","BK4588","BK4104","VXUS","BK1161","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172657278","title":"Movement Alert｜Alebund Pharmaceuticals-B Falls 7.56% in Regular Trading, Post-IPO Volatile Pattern Persists as Stock Retreats Over 40% From High","url":"https://stock-news.laohu8.com/highlight/detail?id=1172657278","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172657278?lang=en_us&edition=fundamental","pubTime":"2026-07-13 09:48","pubTimestamp":1783907285,"startTime":"0","endTime":"0","summary":"On July 13, Alebund Pharmaceuticals-B fell 7.56% in regular trading, trading at 27.42 HKD/share, with turnover of HKD 2.1965 million.The stock has experienced sharp volatility since listing on June...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179897569","title":"Movement Alert｜Alebund Pharmaceuticals-B Declines 5.26% in Regular Trading, Post-IPO Volatile Pattern Extends as Short-Term Profit-Taking Continues","url":"https://stock-news.laohu8.com/highlight/detail?id=1179897569","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179897569?lang=en_us&edition=fundamental","pubTime":"2026-07-10 15:41","pubTimestamp":1783669283,"startTime":"0","endTime":"0","summary":"On July 10, Alebund Pharmaceuticals-B (09637.HK) fell 5.26% in regular trading, trading at HK$28.48/share, with turnover of HK$6.41 million. The decline marks a second consecutive session of selling...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148369112","title":"Movement Alert｜Alebund Pharmaceuticals-B Falls 5.4% in Regular Trading, Short-Term Profit-Taking After Prior Session Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=1148369112","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148369112?lang=en_us&edition=fundamental","pubTime":"2026-07-09 10:21","pubTimestamp":1783563702,"startTime":"0","endTime":"0","summary":"On July 9, Alebund Pharmaceuticals-B declined 5.4% in regular trading, trading at approximately 31.4 HKD/share, with turnover of HKD 2.91 million. The pullback follows the previous session's sharp...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157702683","title":"ALEBUND-B Shares Surge Over 10% Intraday Following Significant Stake Increases by GIC and LAV","url":"https://stock-news.laohu8.com/highlight/detail?id=1157702683","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157702683?lang=en_us&edition=fundamental","pubTime":"2026-07-08 11:25","pubTimestamp":1783481130,"startTime":"0","endTime":"0","summary":"Shares of ALEBUND-B (HKEX: 09637) surged more than 10% during intraday trading. At the time of writing, the stock is up 7.20%, trading at HK$31.28 with a turnover of HK$9.07 million. On June 29, the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","BK1574","09637","BK1515","BK4104","09939","GIC","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183574653","title":"Movement Alert｜Alebund Pharmaceuticals-B Rises 5.07% in Regular Trading, Post-IPO Recovery Extends on Institutional Backing and NDA Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=1183574653","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183574653?lang=en_us&edition=fundamental","pubTime":"2026-07-08 10:00","pubTimestamp":1783476037,"startTime":"0","endTime":"0","summary":"On July 8, Alebund Pharmaceuticals-B rose 5.07% in regular trading, trading at 31.3 HKD/share, with turnover of approximately 4 million HKD.The stock continues its short-term recovery trajectory...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108778007","title":"Movement Alert｜Alebund Pharmaceuticals-B Falls 8.32% in Regular Trading, Post-IPO Correction Extends After First-Day Doubling","url":"https://stock-news.laohu8.com/highlight/detail?id=1108778007","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108778007?lang=en_us&edition=fundamental","pubTime":"2026-07-06 09:38","pubTimestamp":1783301887,"startTime":"0","endTime":"0","summary":"On July 6, Alebund Pharmaceuticals-B (09637.HK) declined 8.32% in regular trading, trading at 28.22 HKD/share, with turnover of approximately 2 million HKD.The decline represents a continuation of...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648693279","title":"Alebund Pharmaceuticals Jiangsu (SEHK:9637) Jumps After IPO But Is The Valuation Already Priced In","url":"https://stock-news.laohu8.com/highlight/detail?id=2648693279","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648693279?lang=en_us&edition=fundamental","pubTime":"2026-07-04 07:25","pubTimestamp":1783121101,"startTime":"0","endTime":"0","summary":"Alebund Pharmaceuticals (Jiangsu) (SEHK:9637) has just completed a HK$1.28b IPO in Hong Kong, an event that brings new attention to its kidney disease drug pipeline and newly listed H shares.\nSee our latest analysis for Alebund Pharmaceuticals (Jiangsu).\nThe strong first day reception for Alebund Pharmaceuticals (Jiangsu) has been followed by a 1 day share price return of 18.75% to HK$30.28, although the share price return year to date is down 34.17%. This suggests short term momentum is...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9637/alebund-pharmaceuticals-jiangsu-shares/news/alebund-pharmaceuticals-jiangsu-sehk9637-jumps-after-ipo-but","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9637/alebund-pharmaceuticals-jiangsu-shares/news/alebund-pharmaceuticals-jiangsu-sehk9637-jumps-after-ipo-but","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["09637","FRHC","BK4127","IPOS","KCE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125037855","title":"Major Institutional Investors Increase Holdings in ALEBUND-B, Investing Over HK$58 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1125037855","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125037855?lang=en_us&edition=fundamental","pubTime":"2026-07-03 18:12","pubTimestamp":1783073561,"startTime":"0","endTime":"0","summary":"On June 29, ALEBUND-B (HKEX: 09637) saw simultaneous share purchases from two of its significant institutional shareholders.One investor, Global Industry Company, acquired 872,000 shares at an...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4104","BK1161","BK1515","09939","159938","GIC","BK1574","09637"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108352969","title":"ALEBUND-B Shares Surge Over 13% in Early Trading as AP301 Nears Commercial Launch Following Recent Sell-Off","url":"https://stock-news.laohu8.com/highlight/detail?id=1108352969","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108352969?lang=en_us&edition=fundamental","pubTime":"2026-07-03 10:38","pubTimestamp":1783046307,"startTime":"0","endTime":"0","summary":"Shares of ALEBUND-B (HKEX: 09637) climbed more than 13% in the morning session. At the time of writing, the stock was up 10.75% to HK$28.24, with a turnover of HK$8.44 million. According to industry...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK4588","BK1161","159938","BK1515","BK4585","09637","09939","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110040066","title":"Movement Alert｜Alebund Pharmaceuticals-B Rises 7.92% in Regular Trading, Trading at 28.74 HKD","url":"https://stock-news.laohu8.com/highlight/detail?id=1110040066","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110040066?lang=en_us&edition=fundamental","pubTime":"2026-07-03 09:50","pubTimestamp":1783043406,"startTime":"0","endTime":"0","summary":"On July 3, Alebund Pharmaceuticals-B (09637.HK) rose 7.92% in regular trading, trading at 28.74 HKD/share, with turnover of approximately 4.98 million HKD.Alebund Pharmaceuticals listed on the Hong...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09637"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":57,"code":"91000000","status":"200"}]}}